Recent developments in disease activity indices and outcome measures for juvenile idiopathic arthritis.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 39
- By:
- Publication type:
- Article
Works matching IS 02613360 AND DT 2014 AND VI 33 AND IP 1
Results: 38
1
2
Cross-sectional and longitudinal evaluation of bone mass and quality in children and young adults with juvenile onset systemic lupus erythematosus (JSLE): role of bone mass determinants analyzed by DXA, PQCT and QUS.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 38
- By:
- Publication type:
- Article
3
Risk markers of juvenile idiopathic arthritis-associated uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 37
- By:
- Publication type:
- Article
4
Sleep and its relationship to pain, dysfunction, and disease activity in juvenile idiopathic arthritis.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 36
- By:
- Publication type:
- Article
5
Inflammatory changes of the lumbar spine in children and adolescents with enthesitis related arthritis; magnetic resonance imaging findings.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 35
- By:
- Publication type:
- Article
6
Paediatric rheumatology practice in the UK benchmarked against the British Society for Paediatric and Adolescent Rheumatology/Arthritis and Musculoskeletal Alliance Standards of Care for juvenile idiopathic arthritis.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 34
- By:
- Publication type:
- Article
7
International consensus for provisions of quality-driven care in childhood-onset systemic lupus erythematosus.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 33
- By:
- Publication type:
- Article
8
Study of audiovestibular dysfunction in children with systemic lupus erythematosus.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 32
- By:
- Publication type:
- Article
9
Disease activity assessment in childhood Vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS).
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 32
- By:
- Publication type:
- Article
10
Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 30
- By:
- Publication type:
- Article
11
Frequency and predictors of premature work loss in primary care consulters for osteoarthritis: prospective cohort study.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 25
- By:
- Publication type:
- Article
12
Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 24
- By:
- Publication type:
- Article
13
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 23
- By:
- Publication type:
- Article
14
Association of gastroesophageal factors and worsening of forced vital capacity in systemic sclerosis.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 23
- By:
- Publication type:
- Article
15
Efficacy and safety of belimumab in primary sjögren's syndrome: results of the BELISS open-label Phase II study.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 31
- By:
- Publication type:
- Article
16
Damage in the ANCA-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAs) therapeutic trials.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 29
- By:
- Publication type:
- Article
17
Cognitive performance is of clinical importance, but is unrelated to pain severity in women with chronic fatigue syndrome.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 28
- By:
- Publication type:
- Article
18
Value of isolated IgA anti-ß2-glycoprotein I positivity in the diagnosis of the antiphospholipid syndrome.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 27
- By:
- Publication type:
- Article
19
The enduring impact of what clinicians say to people with low back pain.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 28
- By:
- Publication type:
- Article
20
Primary male osteoporosis is associated with enhanced glucocorticoid availability.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 26
- By:
- Publication type:
- Article
21
Exercise therapy may postpone total hip replacement surgery in patients with hip osteoarthritis: a long-term follow-up of a randomised trial.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 25
- By:
- Publication type:
- Article
22
Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 22
- By:
- Publication type:
- Article
23
Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 21
- By:
- Publication type:
- Article
24
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS study).
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 20
- By:
- Publication type:
- Article
25
Efficacy and safety of non-biologic immunosuppressants in the treatment of non-renal systemic lupus erythematosus: a systematic review.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 19
- By:
- Publication type:
- Article
26
Prednisone in lupus nephritis: how much is enough?
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 18
- By:
- Publication type:
- Article
27
What do we miss? ASAS non-responders on anti-TNF therapy show improvement in performance-based physical function.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 17
- By:
- Publication type:
- Article
28
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 16
- By:
- Publication type:
- Article
29
Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 15
- By:
- Publication type:
- Article
30
The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 14
- By:
- Publication type:
- Article
31
Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA).
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 14
- By:
- Publication type:
- Article
32
A weighted genetic risk score using all known susceptibility variants to estimate rheumatoid arthritis risk.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 13
- By:
- Publication type:
- Article
33
A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study).
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 12
- By:
- Publication type:
- Article
34
Personalised treatment using serum drug levels of adalimumab in patients with rheumatoid arthritis: an evaluation of costs and effects.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 11
- By:
- Publication type:
- Article
35
Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 10
- By:
- Publication type:
- Article
36
Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 9
- By:
- Publication type:
- Article
37
Novel Biomarkers and Myositis-specific Autoantibodies in the Management of Idiopathic Inflammatory Myopathies.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 1
- By:
- Publication type:
- Article
38
Foreword.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. IV
- By:
- Publication type:
- Article